Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial (Q28346269)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial
scientific article

    Statements

    Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial (English)
    0 references
    0 references
    0 references
    M Verlinden
    0 references
    D J Geenen
    0 references
    R B Hogan
    0 references
    D Riff
    0 references
    R W McCallum
    0 references
    R J Mack
    0 references
    September 2001
    0 references
    0 references
    49
    0 references
    395-401
    0 references
    3
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit